The document discusses cell division and the cell cycle. It notes that cell division is necessary for growth, repair, and reproduction. There are two main types of cell division: mitosis and meiosis. Mitosis produces identical daughter cells and is involved in growth and repair, while meiosis occurs in sex cells and involves genetic variation. The cell cycle consists of interphase and mitosis. Interphase prepares the cell for division and consists of G1, S, and G2 phases. Mitosis then divides the cell into two identical daughter cells. Cancer occurs when cell division becomes uncontrolled and cells fail to differentiate. The document provides details on various stages of the cell cycle and cell division.
Deciphering signaling mechanisms of cartilage tissue engineered alginate scaf...Antonion Korcari
Combination of Systems Biology and Tissue Engineering approaches by creating a mechanism for 3D cartilage phenotype evaluation. More specifically, high-throughput measurements have been used to interrogate intracellular and extracellular activity of 3D cultured chondrocytes, combined with phenotypic measurements of cartilage growth (s-GAG) to correlate the mechanism of cartilage growth, either untreated or treated with different stimuli.
This study encapsulated equine endothelial progenitor cells and mesenchymal stem cells alone and in co-culture within a PEG-fibrinogen hydrogel scaffold to assess neovascularization. Equine EPCs formed tubules within 1 day when encapsulated alone or with MSCs, and vascularization increased over 4 days. Tubules did not form with MSCs alone. The hydrogel scaffold supported long-term cell viability and vascular structure formation, demonstrating its potential for tissue engineering and wound healing applications in horses. Future work will quantify vessel formation to determine scaffold thickness and MSC effects.
This document discusses cartilage damage and potential treatments using tissue engineering. It describes how cartilage has limited ability for self-repair and can be damaged by trauma or arthritis. Two potential treatments are discussed: (1) Isolating and seeding chondrocytes cells on scaffolds to repair cartilage, and (2) Using mesenchymal stem cells (MSCs) that can differentiate into chondrocytes when implanted on scaffolds. The document evaluates studies comparing the effectiveness of these two approaches for cartilage regeneration and repair.
This document provides an overview of tissue engineering of bone. It discusses the objectives of understanding bone formation/repair and the components of bone tissue engineering. The key components are scaffolds, growth factors, and cells. Various materials are described for use as scaffolds, including metals, ceramics, and polymers. Growth factors can stimulate bone formation and fracture healing. In vitro models are used to test and screen growth factors and their effects on bone marrow stem cells and cell lines prior to in vivo studies. Bone's macroscopic structure and the processes of intramembranous and endochondral bone formation are also summarized.
Microgravity is the condition in which people or objects appear to be weightless (In space). Astronauts and cosmonauts returning from long-term space missions exhibited various health problems, among them changes of the immune system, bone loss, muscle atrophy, ocular problems, and cardiovascular changes. Space biologists investigated various cell types in space to find the molecular mechanisms responsible for the observed immune disorders. Experimental cell research studying three-dimensional (3D) tissues in space and on Earth using new techniques to simulate microgravity is currently a hot topic in Gravitational Biology and Biomedicine.
Tissue engineering and regenerative medicine Suman Nandy
Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a scaffold for the formation of new viable tissue for a medical purpose.
This document provides an overview of cardiac tissue engineering. It discusses the use of biomaterials like scaffolds and hydrogels to support cells for growing new cardiac tissue. Common cell types used include stem cells and differentiated cardiac cells. Tissue engineered constructs aim to be biocompatible, functional and living to replace damaged heart tissue like blood vessels, heart valves, and myocardial patches. Recent developments include engineered tissues that closely mimic heart muscle mechanics and biology.
Tissue engineering involves growing tissues or organs by seeding cells onto biodegradable scaffolds. There are several key steps in the tissue engineering process: (1) cells are isolated from a patient and cultured, (2) the cells are seeded onto a scaffold to allow adhesion and growth, (3) the seeded scaffolds may be placed in a bioreactor to mimic the body's conditions and stimulate growth, (4) the engineered tissues are implanted into the patient. Bioreactors help distribute cells throughout the scaffold and provide mechanical and chemical cues to influence cell behavior.
Deciphering signaling mechanisms of cartilage tissue engineered alginate scaf...Antonion Korcari
Combination of Systems Biology and Tissue Engineering approaches by creating a mechanism for 3D cartilage phenotype evaluation. More specifically, high-throughput measurements have been used to interrogate intracellular and extracellular activity of 3D cultured chondrocytes, combined with phenotypic measurements of cartilage growth (s-GAG) to correlate the mechanism of cartilage growth, either untreated or treated with different stimuli.
This study encapsulated equine endothelial progenitor cells and mesenchymal stem cells alone and in co-culture within a PEG-fibrinogen hydrogel scaffold to assess neovascularization. Equine EPCs formed tubules within 1 day when encapsulated alone or with MSCs, and vascularization increased over 4 days. Tubules did not form with MSCs alone. The hydrogel scaffold supported long-term cell viability and vascular structure formation, demonstrating its potential for tissue engineering and wound healing applications in horses. Future work will quantify vessel formation to determine scaffold thickness and MSC effects.
This document discusses cartilage damage and potential treatments using tissue engineering. It describes how cartilage has limited ability for self-repair and can be damaged by trauma or arthritis. Two potential treatments are discussed: (1) Isolating and seeding chondrocytes cells on scaffolds to repair cartilage, and (2) Using mesenchymal stem cells (MSCs) that can differentiate into chondrocytes when implanted on scaffolds. The document evaluates studies comparing the effectiveness of these two approaches for cartilage regeneration and repair.
This document provides an overview of tissue engineering of bone. It discusses the objectives of understanding bone formation/repair and the components of bone tissue engineering. The key components are scaffolds, growth factors, and cells. Various materials are described for use as scaffolds, including metals, ceramics, and polymers. Growth factors can stimulate bone formation and fracture healing. In vitro models are used to test and screen growth factors and their effects on bone marrow stem cells and cell lines prior to in vivo studies. Bone's macroscopic structure and the processes of intramembranous and endochondral bone formation are also summarized.
Microgravity is the condition in which people or objects appear to be weightless (In space). Astronauts and cosmonauts returning from long-term space missions exhibited various health problems, among them changes of the immune system, bone loss, muscle atrophy, ocular problems, and cardiovascular changes. Space biologists investigated various cell types in space to find the molecular mechanisms responsible for the observed immune disorders. Experimental cell research studying three-dimensional (3D) tissues in space and on Earth using new techniques to simulate microgravity is currently a hot topic in Gravitational Biology and Biomedicine.
Tissue engineering and regenerative medicine Suman Nandy
Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a scaffold for the formation of new viable tissue for a medical purpose.
This document provides an overview of cardiac tissue engineering. It discusses the use of biomaterials like scaffolds and hydrogels to support cells for growing new cardiac tissue. Common cell types used include stem cells and differentiated cardiac cells. Tissue engineered constructs aim to be biocompatible, functional and living to replace damaged heart tissue like blood vessels, heart valves, and myocardial patches. Recent developments include engineered tissues that closely mimic heart muscle mechanics and biology.
Tissue engineering involves growing tissues or organs by seeding cells onto biodegradable scaffolds. There are several key steps in the tissue engineering process: (1) cells are isolated from a patient and cultured, (2) the cells are seeded onto a scaffold to allow adhesion and growth, (3) the seeded scaffolds may be placed in a bioreactor to mimic the body's conditions and stimulate growth, (4) the engineered tissues are implanted into the patient. Bioreactors help distribute cells throughout the scaffold and provide mechanical and chemical cues to influence cell behavior.
This document discusses tissue engineering and the use of scaffolds for growing cells. It describes several scaffold design techniques including nanofibre self-assembly, gas foaming, CAD/CAM technologies, and electrospinning. Scaffolds provide a structure for cells to attach, migrate, and grow into tissues. The future of this technology could enable the creation of more complex organs and possibly whole bodies. However, issues around cost and ethics will need to be addressed as the technology advances.
This document summarizes tissue engineering approaches for engineering cardiovascular tissues. It discusses how cardiovascular disease is a leading cause of death and current treatment limitations. The main targets for tissue engineering are blood vessels, heart muscle, and heart valves. Commonly used biomaterials include polymeric scaffolds, hydrogels, and decellularized tissues. Appropriate cell types and biomolecules are also discussed. The challenges of engineering different cardiovascular tissues like blood vessels, heart valves, and heart muscle are briefly outlined.
Tissue engineering aims to regenerate tissues by combining cells, scaffolds, and signaling molecules. There are two main strategies - in vitro construction of tissues in the lab prior to implantation, and in vivo regeneration of tissues at the implantation site. Successful tissue engineering requires the right cells, scaffolding for cell attachment and growth, and signaling to guide tissue development. Stem cells are promising cell sources due to their ability to differentiate into many cell types.
1) The document discusses the concept of an in vivo bioreactor (IVB), which aims to produce organs and tissues within the body by bypassing traditional tissue engineering steps. 2) Key criteria for an IVB include identifying a location with pluripotent cells, establishing an environment excluding other cells, presenting a single cue overriding biological noise, and defining a regenerative volume. 3) Early successes include engineering bone and cartilage in vivo through injection of calcium alginate or agarose gels in the subperiosteal space to direct cell fate.
The document summarizes recent applications of tissue engineering principles in orthopaedics. It discusses how scaffolds, signals, and cells have been combined in various tissue engineering strategies to treat fracture nonunions, osteonecrosis, and chondral/osteochondral defects. For fracture nonunions, delivering mesenchymal stem cells on an atelocollagen scaffold improved healing rates. Treating osteonecrosis with autologous mesenchymal stem cells seeded on bone grafts showed prevention of disease progression in some cases. Cell doses and scaffold properties were found to influence outcomes. Tissue engineering approaches for cartilage defects, including cell injections and composite scaffolds, demonstrated symptom improvement over baseline.
This thesis examines the differentiation of human induced pluripotent stem cells (iPSCs) to oligodendrocyte progenitor cells (OPCs). The document provides background on spinal cord injury and the role of oligodendrocytes. It then describes the differentiation protocol employed, which initially forms cell aggregates from iPSCs and directs their differentiation to an OPC fate over 20 days. The results demonstrate the initial aggregation of iPSCs and maturation of aggregates into OPC-like cells expressing markers like Olig2, PDGFRα, and NG2. This protocol aims to generate OPCs from human iPSCs for potential use in treating demyelinating conditions of the central nervous system.
Biomaterials were defined as “any substance, other than a drug, or a combination of substances, synthetic or natural in origin, which can be used for any period of time, as a whole or as a part of a system, which treats, augments or replaces any tissue, organ or function of the body”
This document discusses using poly(L-lactic acid) (PLLA) scaffolds for cartilage tissue engineering. PLLA is a suitable scaffold material because it degrades at a rate that allows new tissue to form while providing structural support. A study seeded mesenchymal stem cells onto PLLA scaffolds and found the cells adhered uniformly and differentiated into chondrocytes, expressing cartilage markers and forming extracellular matrix. PLLA scaffolds have advantages like an ideal degradation rate that matches tissue growth and causes less inflammation than other materials. This makes PLLA scaffolds a promising option for cartilage regeneration applications.
Tissue engineering uses scaffolds, cells, and signaling molecules to regenerate tissues and organs. Scaffolds provide a structure for cell attachment, growth, and tissue formation. Natural polymers like collagen and hyaluronic acid, and synthetic polymers like poly-lactic-co-glycolic acid are commonly used as scaffold materials. Scaffolds can be fabricated using various methods including freeze drying, electrospinning, 3D printing, and textile technologies to produce scaffolds with desirable properties like porosity and pore size for tissue growth. Scaffolds seeded with stem cells or tissue-specific cells aim to repair and regenerate tissues for applications in skin, bone, cartilage, and other organs.
This document discusses tissue engineering approaches and cell sources. It defines tissue engineering as using cells, engineering, and materials to improve or replace biological functions. Tissue engineering offers opportunities like creating implants and studying stem cells. The main approaches are using instructive environments to guide regeneration, delivering cells/factors, and culturing cells on scaffolds. Sources of cells discussed include induced pluripotent stem cells, fetal/umbilical cord cells, and various adult cells like mesenchymal stem cells. Scaffolds are also discussed as a key element, with properties like porosity and factors released. Both in vitro and in vivo strategies can be used.
1. Tissue engineering involves growing tissues or organs in vitro to replace damaged body parts. Cells are seeded onto a scaffold and bathed in growth factors to grow new tissue.
2. Common scaffolds include collagen, polymers like PLLA, and ceramics. Cells used include stem cells, keratinocytes for skin, and bladder cells.
3. The process involves obtaining cells, seeding them onto a scaffold, and incubating the construct to grow new tissue which can then be implanted.
Tissue engineering in heart and valve failure management.drucsamal
This document summarizes research on tissue engineering approaches for treating heart and valve failure. It discusses developing cardiac patches made of biomaterials seeded with cells, testing patches in animal models, and evaluating function. Heart valve engineering using scaffolds seeded with human cells is also reviewed. Whole heart engineering by decellularizing and repopulating rat hearts is presented. Clinical perspectives are discussed, such as enrolling patients for efficacy tests of engineered myocardial tissue and assessing safety issues. The goal is developing tissue engineering therapies for treating unmet clinical needs in heart disease.
Stem Cells,BMAC,PRP,Scaffold,Regenerative Medicine,Chondrocytes,Mesenchymal cells,FUTURE ORTHOPEDICS BASICS OF STEM CELLS AND TISSUE ENGINEERING Dr.Sandeep C Agrawal Gondia Maharashtra India
The document describes an experiment that tested the effects of simulated microgravity on chondrocyte cells. Chondrocyte cells were placed in a cell rocker to simulate microgravity conditions and their growth and death were monitored over multiple days. As hypothesized, the cells exposed to simulated microgravity initially increased in number but then began degrading and dying off at an exponential rate. In contrast, the control cells in normal gravity conditions remained stable. The results supported the idea that microgravity causes degradation of the cells responsible for maintaining cartilage.
This document discusses bioengineering, stem cells, and bioprinting. It explains that tissue engineering applies principles of engineering and life sciences to develop biological substitutes that restore or improve organ/tissue function. The methodology involves recruiting cells, interacting them with biomaterials, and implanting seeded matrices. Normal cell structures and functions are also described, including the plasma membrane, cytoskeleton, extracellular matrix, and mechanisms of cell-ECM and cell-biomaterial interaction. Potential cell sources for tissue engineering are discussed.
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Despite advances in organ transplantation, thousands still die each year waiting for donor organs. Tissue engineering aims to construct artificial organs and tissues in vitro by combining cells, biomaterials, and growth factors to replace diseased organs. Some key challenges include developing scaffolds that mimic the extracellular matrix, integrating multiple cell types, and applying mechanical and chemical signals to direct tissue development. While tissue engineering has shown promise for tissues like bone and skin, fully regenerating complex organs that do not naturally regenerate has yet to be achieved. Further research is still needed to meet clinical and patient expectations for safety, effectiveness and cost.
Tissue engineering aims to reconstruct tissues and organs by growing new tissue from cells onto a scaffold. It provides an alternative to transplantation by producing tissues customized for patients. Recent advances include improved scaffold materials for bone tissue engineering using osteoinductive and hybrid materials. Scientists have also engineered heart and nerve tissues that closely mimic natural tissues, with the heart tissue even beating when implanted. Tissue engineering holds promise for treating currently untreatable medical conditions but further research is still needed.
Tissue engineering and stem cell by regenerative medicine.pptx badal 2014Pradeep Kumar
The document discusses the history and applications of tissue engineering using stem cells for regenerative medicine. It provides background on the field of tissue engineering and milestones from the 1960s to present. It describes different types of stem cells like hematopoietic, mesenchymal, embryonic and their uses. Applications discussed include using stem cells to treat diseases like cardiovascular disease, diabetes, and neurological disorders. Recent advances mentioned are growing tissues like ears, noses, kidneys and pancreatic islets using 3D printing and scaffolds. The document concludes by noting both the promise and challenges of tissue engineering for regenerative medicine.
Cell division is essential but must be controlled. There are two phases of cell division - interphase and mitosis. Interphase is the non-dividing phase where the cell grows and carries out normal functions. Mitosis is the dividing phase where the nucleus divides into two identical daughter nuclei through the stages of prophase, metaphase, anaphase and telophase. Cytokinesis then divides the cytoplasm. Chromosomes condense through supercoiling during mitosis. Cyclins control progression through the cell cycle. Mutations from mutagens can lead to cancer development if they occur in oncogenes and are not repaired. Smoking strongly correlates with increased lung cancer rates, with a lag time between smoking and cancer development
This document discusses tissue engineering and the use of scaffolds for growing cells. It describes several scaffold design techniques including nanofibre self-assembly, gas foaming, CAD/CAM technologies, and electrospinning. Scaffolds provide a structure for cells to attach, migrate, and grow into tissues. The future of this technology could enable the creation of more complex organs and possibly whole bodies. However, issues around cost and ethics will need to be addressed as the technology advances.
This document summarizes tissue engineering approaches for engineering cardiovascular tissues. It discusses how cardiovascular disease is a leading cause of death and current treatment limitations. The main targets for tissue engineering are blood vessels, heart muscle, and heart valves. Commonly used biomaterials include polymeric scaffolds, hydrogels, and decellularized tissues. Appropriate cell types and biomolecules are also discussed. The challenges of engineering different cardiovascular tissues like blood vessels, heart valves, and heart muscle are briefly outlined.
Tissue engineering aims to regenerate tissues by combining cells, scaffolds, and signaling molecules. There are two main strategies - in vitro construction of tissues in the lab prior to implantation, and in vivo regeneration of tissues at the implantation site. Successful tissue engineering requires the right cells, scaffolding for cell attachment and growth, and signaling to guide tissue development. Stem cells are promising cell sources due to their ability to differentiate into many cell types.
1) The document discusses the concept of an in vivo bioreactor (IVB), which aims to produce organs and tissues within the body by bypassing traditional tissue engineering steps. 2) Key criteria for an IVB include identifying a location with pluripotent cells, establishing an environment excluding other cells, presenting a single cue overriding biological noise, and defining a regenerative volume. 3) Early successes include engineering bone and cartilage in vivo through injection of calcium alginate or agarose gels in the subperiosteal space to direct cell fate.
The document summarizes recent applications of tissue engineering principles in orthopaedics. It discusses how scaffolds, signals, and cells have been combined in various tissue engineering strategies to treat fracture nonunions, osteonecrosis, and chondral/osteochondral defects. For fracture nonunions, delivering mesenchymal stem cells on an atelocollagen scaffold improved healing rates. Treating osteonecrosis with autologous mesenchymal stem cells seeded on bone grafts showed prevention of disease progression in some cases. Cell doses and scaffold properties were found to influence outcomes. Tissue engineering approaches for cartilage defects, including cell injections and composite scaffolds, demonstrated symptom improvement over baseline.
This thesis examines the differentiation of human induced pluripotent stem cells (iPSCs) to oligodendrocyte progenitor cells (OPCs). The document provides background on spinal cord injury and the role of oligodendrocytes. It then describes the differentiation protocol employed, which initially forms cell aggregates from iPSCs and directs their differentiation to an OPC fate over 20 days. The results demonstrate the initial aggregation of iPSCs and maturation of aggregates into OPC-like cells expressing markers like Olig2, PDGFRα, and NG2. This protocol aims to generate OPCs from human iPSCs for potential use in treating demyelinating conditions of the central nervous system.
Biomaterials were defined as “any substance, other than a drug, or a combination of substances, synthetic or natural in origin, which can be used for any period of time, as a whole or as a part of a system, which treats, augments or replaces any tissue, organ or function of the body”
This document discusses using poly(L-lactic acid) (PLLA) scaffolds for cartilage tissue engineering. PLLA is a suitable scaffold material because it degrades at a rate that allows new tissue to form while providing structural support. A study seeded mesenchymal stem cells onto PLLA scaffolds and found the cells adhered uniformly and differentiated into chondrocytes, expressing cartilage markers and forming extracellular matrix. PLLA scaffolds have advantages like an ideal degradation rate that matches tissue growth and causes less inflammation than other materials. This makes PLLA scaffolds a promising option for cartilage regeneration applications.
Tissue engineering uses scaffolds, cells, and signaling molecules to regenerate tissues and organs. Scaffolds provide a structure for cell attachment, growth, and tissue formation. Natural polymers like collagen and hyaluronic acid, and synthetic polymers like poly-lactic-co-glycolic acid are commonly used as scaffold materials. Scaffolds can be fabricated using various methods including freeze drying, electrospinning, 3D printing, and textile technologies to produce scaffolds with desirable properties like porosity and pore size for tissue growth. Scaffolds seeded with stem cells or tissue-specific cells aim to repair and regenerate tissues for applications in skin, bone, cartilage, and other organs.
This document discusses tissue engineering approaches and cell sources. It defines tissue engineering as using cells, engineering, and materials to improve or replace biological functions. Tissue engineering offers opportunities like creating implants and studying stem cells. The main approaches are using instructive environments to guide regeneration, delivering cells/factors, and culturing cells on scaffolds. Sources of cells discussed include induced pluripotent stem cells, fetal/umbilical cord cells, and various adult cells like mesenchymal stem cells. Scaffolds are also discussed as a key element, with properties like porosity and factors released. Both in vitro and in vivo strategies can be used.
1. Tissue engineering involves growing tissues or organs in vitro to replace damaged body parts. Cells are seeded onto a scaffold and bathed in growth factors to grow new tissue.
2. Common scaffolds include collagen, polymers like PLLA, and ceramics. Cells used include stem cells, keratinocytes for skin, and bladder cells.
3. The process involves obtaining cells, seeding them onto a scaffold, and incubating the construct to grow new tissue which can then be implanted.
Tissue engineering in heart and valve failure management.drucsamal
This document summarizes research on tissue engineering approaches for treating heart and valve failure. It discusses developing cardiac patches made of biomaterials seeded with cells, testing patches in animal models, and evaluating function. Heart valve engineering using scaffolds seeded with human cells is also reviewed. Whole heart engineering by decellularizing and repopulating rat hearts is presented. Clinical perspectives are discussed, such as enrolling patients for efficacy tests of engineered myocardial tissue and assessing safety issues. The goal is developing tissue engineering therapies for treating unmet clinical needs in heart disease.
Stem Cells,BMAC,PRP,Scaffold,Regenerative Medicine,Chondrocytes,Mesenchymal cells,FUTURE ORTHOPEDICS BASICS OF STEM CELLS AND TISSUE ENGINEERING Dr.Sandeep C Agrawal Gondia Maharashtra India
The document describes an experiment that tested the effects of simulated microgravity on chondrocyte cells. Chondrocyte cells were placed in a cell rocker to simulate microgravity conditions and their growth and death were monitored over multiple days. As hypothesized, the cells exposed to simulated microgravity initially increased in number but then began degrading and dying off at an exponential rate. In contrast, the control cells in normal gravity conditions remained stable. The results supported the idea that microgravity causes degradation of the cells responsible for maintaining cartilage.
This document discusses bioengineering, stem cells, and bioprinting. It explains that tissue engineering applies principles of engineering and life sciences to develop biological substitutes that restore or improve organ/tissue function. The methodology involves recruiting cells, interacting them with biomaterials, and implanting seeded matrices. Normal cell structures and functions are also described, including the plasma membrane, cytoskeleton, extracellular matrix, and mechanisms of cell-ECM and cell-biomaterial interaction. Potential cell sources for tissue engineering are discussed.
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Despite advances in organ transplantation, thousands still die each year waiting for donor organs. Tissue engineering aims to construct artificial organs and tissues in vitro by combining cells, biomaterials, and growth factors to replace diseased organs. Some key challenges include developing scaffolds that mimic the extracellular matrix, integrating multiple cell types, and applying mechanical and chemical signals to direct tissue development. While tissue engineering has shown promise for tissues like bone and skin, fully regenerating complex organs that do not naturally regenerate has yet to be achieved. Further research is still needed to meet clinical and patient expectations for safety, effectiveness and cost.
Tissue engineering aims to reconstruct tissues and organs by growing new tissue from cells onto a scaffold. It provides an alternative to transplantation by producing tissues customized for patients. Recent advances include improved scaffold materials for bone tissue engineering using osteoinductive and hybrid materials. Scientists have also engineered heart and nerve tissues that closely mimic natural tissues, with the heart tissue even beating when implanted. Tissue engineering holds promise for treating currently untreatable medical conditions but further research is still needed.
Tissue engineering and stem cell by regenerative medicine.pptx badal 2014Pradeep Kumar
The document discusses the history and applications of tissue engineering using stem cells for regenerative medicine. It provides background on the field of tissue engineering and milestones from the 1960s to present. It describes different types of stem cells like hematopoietic, mesenchymal, embryonic and their uses. Applications discussed include using stem cells to treat diseases like cardiovascular disease, diabetes, and neurological disorders. Recent advances mentioned are growing tissues like ears, noses, kidneys and pancreatic islets using 3D printing and scaffolds. The document concludes by noting both the promise and challenges of tissue engineering for regenerative medicine.
Cell division is essential but must be controlled. There are two phases of cell division - interphase and mitosis. Interphase is the non-dividing phase where the cell grows and carries out normal functions. Mitosis is the dividing phase where the nucleus divides into two identical daughter nuclei through the stages of prophase, metaphase, anaphase and telophase. Cytokinesis then divides the cytoplasm. Chromosomes condense through supercoiling during mitosis. Cyclins control progression through the cell cycle. Mutations from mutagens can lead to cancer development if they occur in oncogenes and are not repaired. Smoking strongly correlates with increased lung cancer rates, with a lag time between smoking and cancer development
Cell size is limited by the ratio of surface area to volume. As cells grow, their volume increases more rapidly than their surface area, making it difficult to supply nutrients and remove waste. The cell cycle, which involves growth and division, prevents cells from becoming too large. Mitosis and cytokinesis allow cells to accurately divide their DNA and contents between two daughter cells. Checkpoints in the cell cycle monitor for errors to maintain genetic integrity. Cancer occurs when cells lose cell cycle regulation and divide uncontrollably. Apoptosis and stem cells are also important cellular processes related to growth, maintenance, and repair of tissues.
Cell cycle and cell division are fundamental processes governing the growth, development, and reproduction of all living organisms. Understanding these processes is crucial in the field of biology as they play a pivotal role in shaping life at both the cellular and organismal levels.
For more information, visit-www.vavaclasses.com
This document discusses stem cells and their therapeutic applications. It begins by explaining how the early embryo develops from a single cell through cell division and differentiation. It then defines different types of stem cells based on their potency. The document presents two case studies of using stem cells therapeutically: one for treating Stargardt's macular degeneration by injecting retinal stem cells, and one for treating leukemia by harvesting a patient's stem cells and reintroducing them after chemotherapy. Finally, it discusses the sources of stem cells including embryonic, adult, and induced pluripotent stem cells as well as the ongoing ethical debate around stem cell research.
This document provides information about eukaryotic cells. It includes diagrams and descriptions of key structures in animal cells like the nucleus, cell membrane, mitochondria, endoplasmic reticulum, Golgi apparatus, lysosomes, and ribosomes. It compares prokaryotic and eukaryotic cells, highlights differences between plant and animal cells, and outlines two roles of extracellular components like bone matrix, basement membranes, and cell walls. The document contains links to additional resources for further information.
This document provides information about cell differentiation from a lecture presented by Dr. SHWETA SINGH. It defines cell differentiation as the process by which a cell undergoes changes in gene expression to become a more specialized cell type. This allows multicellular organisms to develop uniquely functional cell types and body plans. The document discusses how all organisms begin as a single cell and must undergo cell division and differentiation to form the complex tissues and organ systems of the adult body. It provides examples of cell differentiation in animal development and plant growth from a single cell.
Gelatin-based scaffolds: An intuitive support structure for regenerative therapyAdib Bin Rashid
Advanced regenerative therapy aims to repair pathologically
damaged tissue by cell transplantation in conjunction with
supporting scaffolds. Gelatin-based scaffolds have attracted
much attention in recent years due to their great bio-affinity that
encourages the regeneration of tissues. Nowadays, by
strengthening gelatin-based systems, cutting-edge methods like
3D bioprinting, freeze-drying, microfluidics and gelatin functionalization have shown excellent mimicry of natural tissue. The
fabrication of porous gelatin-based scaffolds for wider tissue
engineering applications including skin, cartilage, bone, liver,
and cardiovascular is reviewed in this work. Additionally, the
crosslinking procedures and the physicochemical characteristics of the gelatin-based scaffolds are also studied. Now, gelatin
is considered one of the highest potential biomaterials for
impending trends in which the gelatin-based scaffolds are used
as a support structure for regenerative therapy.
The document outlines the key stages of the cell cycle, including interphase (G1, S, G2 phases), mitosis, and cytokinesis. It describes that interphase involves DNA replication and protein synthesis. The four stages of mitosis are then described: prophase, metaphase, anaphase, and telophase. It is explained that mitosis produces two genetically identical daughter cells through the duplication and separation of chromosomes. Cell division through mitosis is described as essential for growth, development, tissue repair, and asexual reproduction.
This document provides an overview of cell division through mitosis and meiosis. It defines key terms like interphase, prophase, metaphase, anaphase, telophase and cytokinesis. It explains the stages and importance of both mitosis and meiosis. Specifically, mitosis produces genetically identical daughter cells through the division of the nucleus, while meiosis reduces chromosome number by half to produce haploid gametes through two divisions. Uncontrolled mitosis can lead to cancer if chromosomes do not separate properly.
The document discusses carcinogenesis and cancer. It begins with an overview of cell anatomy and the cell cycle, including the phases of interphase and mitosis. It then discusses how abnormalities in cell cycle regulation and checkpoints can lead to uncontrolled cell growth and carcinogenesis. Factors involved in carcinogenesis include oncogenes, tumor suppressor genes, and DNA damage. The document outlines several theories of carcinogenesis and describes the multistage process. It also covers the characteristics, metastatic process, and classification of malignant tumors.
Dr Zahid Azeem, working as Assistant Professor of Biochemistry at Azad Jammu and Kashmir Medical College, Muzaffarabad since 2012.
email; paym_zahid@live.com
1) The cell cycle involves an orderly sequence of events where a cell duplicates its contents and divides into two identical daughter cells. It consists of interphase and M-phase.
2) Interphase involves three stages - G1 for growth, S for DNA replication, and G2 for more growth before division. M-phase is mitosis and cytokinesis where the cell divides.
3) The cell cycle is tightly regulated by cyclins and CDKs. Cyclin levels rise and fall controlling CDK activity and driving the cell through the cycle. Checkpoints ensure replication and division occur accurately.
Cell division allows cells and organisms to grow while maintaining cell size. The cell cycle consists of interphase and mitosis, during which the cell grows and duplicates its DNA (interphase) before dividing into two daughter cells through mitosis and cytokinesis. Cell division is regulated by proteins called cyclins that control the phases of the cell cycle. Cancer occurs when cells lose their ability to regulate growth and division and instead divide uncontrollably.
Cells need to divide for several reasons: as they grow larger it becomes difficult to distribute nutrients and remove waste, maintain DNA function, and have enough surface area for their volume. Before a cell gets too large, it undergoes cell division to split into two daughter cells. Cell division can be asexual, producing genetically identical offspring via binary fission, or sexual, combining the DNA of two parents to generate genetic diversity. The cell cycle is the series of phases cells go through as they grow and prepare to divide, including interphase where the cell grows and DNA replicates, and mitosis where the nucleus divides. Mitosis involves specific phases where chromosomes align and separate before cytokinesis completes the division of the cell contents. Regulatory proteins
Sci 9 Lesson 1 Feb 21 - Ch 5.1 The Cell Cyclemsoonscience
The document discusses the cell cycle and its key stages. It explains that the cell cycle allows cells to divide and multiply, which allows a single fertilized egg cell to develop into a full organism made of trillions of cells. The three main stages of the cell cycle are: 1) Interphase, where the cell grows and prepares for division; 2) Mitosis, where the cell nucleus and its contents divide; and 3) Cytokinesis, where the cell physically divides into two daughter cells. Key cells like stomach and skin cells divide frequently to replace old or damaged cells.
Cell division and the cell cycle were discussed. The cell cycle consists of growth, DNA synthesis, and cell division phases. In eukaryotes, cell division involves mitosis and cytokinesis. Cancer occurs when the cell cycle is deregulated and cells divide uncontrollably.
The document discusses the goals and strategies of Quahog Life Sciences to extend human lifespan. Their goal is to delay aging processes and find solutions to diseases, physical damage, and misdiagnosis that lead to death. They propose strategies like expanding biotechnology to restore youth and health, replacing organs with artificial ones, restoring youthful blood factors, and uploading memories to new bodies. They cite evidence that other species and some human populations have lived over 120 years. Achieving their goals would require developing an artificial intelligence system to analyze the many factors influencing lifespan and health.
The lymphatic system consists of lymph, lymphatic vessels, lymphoid organs and lymphatic tissue distributed throughout the body. It has three main functions: returning tissue fluid to the blood, absorbing fats and fat-soluble vitamins, and helping the body defend against disease. The lymphatic system contains lymph nodes, tonsils, thymus gland, and spleen. Lymph is a fluid similar to plasma that is formed from tissue fluid and drained through lymphatic vessels into the bloodstream.
The lymphatic system consists of lymph, lymphatic vessels, lymphoid organs and lymphatic tissue distributed throughout the body. It has three main functions: returning tissue fluid to the blood, absorbing fats and fat-soluble vitamins, and helping the body defend against disease. The lymphatic system contains lymph nodes, tonsils, thymus gland, and spleen. Lymph is a fluid similar to plasma that is formed from tissue fluid and drained through lymphatic vessels into the bloodstream.
The document discusses the male and female reproductive systems. It describes the hormones involved in controlling the female cycle, including estrogen and progesterone produced by the ovaries. It also discusses testosterone produced by the testes that controls male characteristics. The document summarizes the structure and function of reproductive organs like the breasts, ovaries, uterus, and testes. It also outlines several disorders that can affect the male and female reproductive systems.
This document provides an overview of microbiology. It discusses the historical development of microscopy and the discovery of microorganisms. It then classifies microbes such as bacteria, viruses, fungi and parasites. In particular, it describes bacteria types including shape, growth requirements and diseases caused. It also outlines the body's defenses against infection including mechanical barriers, inflammation, phagocytosis and the immune response.
Microbiology is the study of microorganisms that can only be seen with a microscope. Historical evidence shows early civilizations isolated infected individuals and burned soiled dressings. Girolamo Fracastorius first suggested disease was caused by living germs in 1546. Robert Koch developed culture plates in 1876 and Louis Pasteur developed sterilization methods. Microorganisms include bacteria, viruses, fungi, parasites and can be pathogenic or non-pathogenic. The human body defends against infection through mechanical barriers, inflammation, phagocytosis, and specific and non-specific immune responses using B cells, T cells and antibodies.
This document provides an overview of cells and tissues in the human body. It begins with definitions of the cell and its structures like the nucleus, cytoplasm, and cell membrane. It describes two types of cell division: mitosis and cytokinesis. The document outlines the four basic tissue types - epithelial, connective, muscle and nervous tissue - and provides examples of cells in each type. It details the structures and functions of specific cell organelles and tissue components. Transport systems and specialized cell types are also discussed.
This document provides an overview of the blood and cardiovascular system. It discusses the components and functions of blood, including transportation, regulation, and protection. The document describes the physical characteristics of blood and its components, which include plasma, red blood cells, white blood cells, and platelets. It also examines the formation and life cycle of blood cells, hemoglobin, and conditions that can affect blood counts. Furthermore, the document outlines the body's homeostatic mechanisms for stopping bleeding through vasospasm, platelet plug formation, and blood clotting.
This document discusses the musculoskeletal system, including the skeletal system, joints, and common disorders. It notes that the adult human skeleton has 206 bones, and that joints are where two bones meet to allow movement. It describes the main types of joints - fixed joints, slightly movable joints, and synovial joints, which have synovial fluid and allow the most movement. Within synovial joints it outlines the ball-and-socket, hinge, pivot, gliding, ellipsoidal, and saddle joints. Ligaments connect bone to bone and tendons connect bone to muscle. In conclusion, it briefly discusses common musculoskeletal disorders like osteoarthritis, osteomalacia, and osteoporosis.
This document discusses discharge planning from a hospital. It begins by defining discharge planning as the process of coordinating care between hospitals, community services, and caregivers to ensure continuity of care as patients transition from inpatient to outpatient. An effective multidisciplinary approach is emphasized, involving medical, nursing, allied health, and social services both within the hospital and in the community. The benefits of thorough discharge planning include improved patient outcomes, reduced hospital readmissions, and shorter hospital stays.
This document discusses basic chemistry concepts including matter, elements, atoms, and electron shells. It defines matter as anything that occupies space and has weight, and states that matter exists in three states: solid, liquid, and gas. Elements are the fundamental substances that matter is made of and are composed of identical atoms. Atoms are the smallest unit of an element and consist of protons, neutrons, and electrons. The number of protons determines an element's atomic number, while atomic weight comes from protons and neutrons. Isotopes are forms of the same atom that differ in neutron numbers. Electrons occupy shells surrounding the nucleus in orbits called energy levels. Chemical bonds form as the outer electron shell seeks stability.
The document discusses acid-base balance and regulation in the human body. It states that the body maintains a steady balance between acids and bases through three main mechanisms: buffer systems, the respiratory system, and the renal system. People with conditions like diabetes, COPD, kidney disease, or the elderly are most at risk of acid-base imbalances. The buffer systems act quickly to neutralize acids and maintain blood pH, while the respiratory system removes carbon dioxide and the renal system filters and regulates bicarbonate and acid levels in the blood and urine to further support acid-base balance.
There are three main types of chemical bonds: ionic bonds, covalent bonds, and hydrogen bonds. Ionic bonds involve the transfer of electrons between atoms, covalent bonds involve the sharing of electrons between atoms, and hydrogen bonds are weak attractions between polar molecules containing hydrogen, such as water molecules. Chemical bonds are crucial as they hold atoms and molecules together, allowing for the formation of larger biological compounds like proteins.
Cells require nutrients and a means to transport waste. There are two main types of transport mechanisms - passive and active. Passive mechanisms like diffusion, facilitated diffusion, and osmosis move substances according to concentration gradients without energy usage. Active transport mechanisms like pumps require ATP to move substances against gradients. Other active mechanisms include endocytosis which transports particles into cells, and exocytosis which transports molecules out of cells.
AI in the Workplace Reskilling, Upskilling, and Future Work.pptxSunil Jagani
Discover how AI is transforming the workplace and learn strategies for reskilling and upskilling employees to stay ahead. This comprehensive guide covers the impact of AI on jobs, essential skills for the future, and successful case studies from industry leaders. Embrace AI-driven changes, foster continuous learning, and build a future-ready workforce.
Read More - https://bit.ly/3VKly70
Connector Corner: Seamlessly power UiPath Apps, GenAI with prebuilt connectorsDianaGray10
Join us to learn how UiPath Apps can directly and easily interact with prebuilt connectors via Integration Service--including Salesforce, ServiceNow, Open GenAI, and more.
The best part is you can achieve this without building a custom workflow! Say goodbye to the hassle of using separate automations to call APIs. By seamlessly integrating within App Studio, you can now easily streamline your workflow, while gaining direct access to our Connector Catalog of popular applications.
We’ll discuss and demo the benefits of UiPath Apps and connectors including:
Creating a compelling user experience for any software, without the limitations of APIs.
Accelerating the app creation process, saving time and effort
Enjoying high-performance CRUD (create, read, update, delete) operations, for
seamless data management.
Speakers:
Russell Alfeche, Technology Leader, RPA at qBotic and UiPath MVP
Charlie Greenberg, host
inQuba Webinar Mastering Customer Journey Management with Dr Graham HillLizaNolte
HERE IS YOUR WEBINAR CONTENT! 'Mastering Customer Journey Management with Dr. Graham Hill'. We hope you find the webinar recording both insightful and enjoyable.
In this webinar, we explored essential aspects of Customer Journey Management and personalization. Here’s a summary of the key insights and topics discussed:
Key Takeaways:
Understanding the Customer Journey: Dr. Hill emphasized the importance of mapping and understanding the complete customer journey to identify touchpoints and opportunities for improvement.
Personalization Strategies: We discussed how to leverage data and insights to create personalized experiences that resonate with customers.
Technology Integration: Insights were shared on how inQuba’s advanced technology can streamline customer interactions and drive operational efficiency.
As AI technology is pushing into IT I was wondering myself, as an “infrastructure container kubernetes guy”, how get this fancy AI technology get managed from an infrastructure operational view? Is it possible to apply our lovely cloud native principals as well? What benefit’s both technologies could bring to each other?
Let me take this questions and provide you a short journey through existing deployment models and use cases for AI software. On practical examples, we discuss what cloud/on-premise strategy we may need for applying it to our own infrastructure to get it to work from an enterprise perspective. I want to give an overview about infrastructure requirements and technologies, what could be beneficial or limiting your AI use cases in an enterprise environment. An interactive Demo will give you some insides, what approaches I got already working for real.
Keywords: AI, Containeres, Kubernetes, Cloud Native
Event Link: https://meine.doag.org/events/cloudland/2024/agenda/#agendaId.4211
[OReilly Superstream] Occupy the Space: A grassroots guide to engineering (an...Jason Yip
The typical problem in product engineering is not bad strategy, so much as “no strategy”. This leads to confusion, lack of motivation, and incoherent action. The next time you look for a strategy and find an empty space, instead of waiting for it to be filled, I will show you how to fill it in yourself. If you’re wrong, it forces a correction. If you’re right, it helps create focus. I’ll share how I’ve approached this in the past, both what works and lessons for what didn’t work so well.
"Frontline Battles with DDoS: Best practices and Lessons Learned", Igor IvaniukFwdays
At this talk we will discuss DDoS protection tools and best practices, discuss network architectures and what AWS has to offer. Also, we will look into one of the largest DDoS attacks on Ukrainian infrastructure that happened in February 2022. We'll see, what techniques helped to keep the web resources available for Ukrainians and how AWS improved DDoS protection for all customers based on Ukraine experience
Northern Engraving | Modern Metal Trim, Nameplates and Appliance PanelsNorthern Engraving
What began over 115 years ago as a supplier of precision gauges to the automotive industry has evolved into being an industry leader in the manufacture of product branding, automotive cockpit trim and decorative appliance trim. Value-added services include in-house Design, Engineering, Program Management, Test Lab and Tool Shops.
The Microsoft 365 Migration Tutorial For Beginner.pptxoperationspcvita
This presentation will help you understand the power of Microsoft 365. However, we have mentioned every productivity app included in Office 365. Additionally, we have suggested the migration situation related to Office 365 and how we can help you.
You can also read: https://www.systoolsgroup.com/updates/office-365-tenant-to-tenant-migration-step-by-step-complete-guide/
Conversational agents, or chatbots, are increasingly used to access all sorts of services using natural language. While open-domain chatbots - like ChatGPT - can converse on any topic, task-oriented chatbots - the focus of this paper - are designed for specific tasks, like booking a flight, obtaining customer support, or setting an appointment. Like any other software, task-oriented chatbots need to be properly tested, usually by defining and executing test scenarios (i.e., sequences of user-chatbot interactions). However, there is currently a lack of methods to quantify the completeness and strength of such test scenarios, which can lead to low-quality tests, and hence to buggy chatbots.
To fill this gap, we propose adapting mutation testing (MuT) for task-oriented chatbots. To this end, we introduce a set of mutation operators that emulate faults in chatbot designs, an architecture that enables MuT on chatbots built using heterogeneous technologies, and a practical realisation as an Eclipse plugin. Moreover, we evaluate the applicability, effectiveness and efficiency of our approach on open-source chatbots, with promising results.
"Scaling RAG Applications to serve millions of users", Kevin GoedeckeFwdays
How we managed to grow and scale a RAG application from zero to thousands of users in 7 months. Lessons from technical challenges around managing high load for LLMs, RAGs and Vector databases.
Essentials of Automations: Exploring Attributes & Automation ParametersSafe Software
Building automations in FME Flow can save time, money, and help businesses scale by eliminating data silos and providing data to stakeholders in real-time. One essential component to orchestrating complex automations is the use of attributes & automation parameters (both formerly known as “keys”). In fact, it’s unlikely you’ll ever build an Automation without using these components, but what exactly are they?
Attributes & automation parameters enable the automation author to pass data values from one automation component to the next. During this webinar, our FME Flow Specialists will cover leveraging the three types of these output attributes & parameters in FME Flow: Event, Custom, and Automation. As a bonus, they’ll also be making use of the Split-Merge Block functionality.
You’ll leave this webinar with a better understanding of how to maximize the potential of automations by making use of attributes & automation parameters, with the ultimate goal of setting your enterprise integration workflows up on autopilot.
Introducing BoxLang : A new JVM language for productivity and modularity!Ortus Solutions, Corp
Just like life, our code must adapt to the ever changing world we live in. From one day coding for the web, to the next for our tablets or APIs or for running serverless applications. Multi-runtime development is the future of coding, the future is to be dynamic. Let us introduce you to BoxLang.
Dynamic. Modular. Productive.
BoxLang redefines development with its dynamic nature, empowering developers to craft expressive and functional code effortlessly. Its modular architecture prioritizes flexibility, allowing for seamless integration into existing ecosystems.
Interoperability at its Core
With 100% interoperability with Java, BoxLang seamlessly bridges the gap between traditional and modern development paradigms, unlocking new possibilities for innovation and collaboration.
Multi-Runtime
From the tiny 2m operating system binary to running on our pure Java web server, CommandBox, Jakarta EE, AWS Lambda, Microsoft Functions, Web Assembly, Android and more. BoxLang has been designed to enhance and adapt according to it's runnable runtime.
The Fusion of Modernity and Tradition
Experience the fusion of modern features inspired by CFML, Node, Ruby, Kotlin, Java, and Clojure, combined with the familiarity of Java bytecode compilation, making BoxLang a language of choice for forward-thinking developers.
Empowering Transition with Transpiler Support
Transitioning from CFML to BoxLang is seamless with our JIT transpiler, facilitating smooth migration and preserving existing code investments.
Unlocking Creativity with IDE Tools
Unleash your creativity with powerful IDE tools tailored for BoxLang, providing an intuitive development experience and streamlining your workflow. Join us as we embark on a journey to redefine JVM development. Welcome to the era of BoxLang.
QR Secure: A Hybrid Approach Using Machine Learning and Security Validation F...AlexanderRichford
QR Secure: A Hybrid Approach Using Machine Learning and Security Validation Functions to Prevent Interaction with Malicious QR Codes.
Aim of the Study: The goal of this research was to develop a robust hybrid approach for identifying malicious and insecure URLs derived from QR codes, ensuring safe interactions.
This is achieved through:
Machine Learning Model: Predicts the likelihood of a URL being malicious.
Security Validation Functions: Ensures the derived URL has a valid certificate and proper URL format.
This innovative blend of technology aims to enhance cybersecurity measures and protect users from potential threats hidden within QR codes 🖥 🔒
This study was my first introduction to using ML which has shown me the immense potential of ML in creating more secure digital environments!
"Choosing proper type of scaling", Olena SyrotaFwdays
Imagine an IoT processing system that is already quite mature and production-ready and for which client coverage is growing and scaling and performance aspects are life and death questions. The system has Redis, MongoDB, and stream processing based on ksqldb. In this talk, firstly, we will analyze scaling approaches and then select the proper ones for our system.
AppSec PNW: Android and iOS Application Security with MobSFAjin Abraham
Mobile Security Framework - MobSF is a free and open source automated mobile application security testing environment designed to help security engineers, researchers, developers, and penetration testers to identify security vulnerabilities, malicious behaviours and privacy concerns in mobile applications using static and dynamic analysis. It supports all the popular mobile application binaries and source code formats built for Android and iOS devices. In addition to automated security assessment, it also offers an interactive testing environment to build and execute scenario based test/fuzz cases against the application.
This talk covers:
Using MobSF for static analysis of mobile applications.
Interactive dynamic security assessment of Android and iOS applications.
Solving Mobile app CTF challenges.
Reverse engineering and runtime analysis of Mobile malware.
How to shift left and integrate MobSF/mobsfscan SAST and DAST in your build pipeline.
2. Cell division is necessary for bodily
growth, repair and reproduction
Herlihy 2011, p. 41
2
2
Document Title (Editable via ‘Slide Master’) | Page 2
3. The frequency of cell division varies from
one tissue to the next
Some cells reproduce frequently whereas
some reproduce slowly or not at all
4
3
Document Title (Editable via ‘Slide Master’) | Page 3
4. More than 2,000,000 red blood cells are replaced
every second!
sfdm.scad.edu
4
4
Document Title (Editable via ‘Slide Master’) | Page 4
5. Cells that line the digestive tract are
reproduced very few days …..
scitechdaily.com
5
5
Document Title (Editable via ‘Slide Master’) | Page 5
6. Certain nerve cells in the brain and spinal cord
do not reproduce at all
newswatch.nationalgeographic.com
6
6
Document Title (Editable via ‘Slide Master’) | Page 6
7. There are Two (2) Kinds of Cell
Division
1. Mitosis
2. Meiosis
7
Document Title (Editable via ‘Slide Master’) | Page 7
8. Mitosis
Is involved in bodily growth and repair
Mitosis involves the splitting of one mother
cell into two (2) identical “daughter cells”
Herlihy 2011, p.41
8
Document Title (Editable via ‘Slide Master’) | Page 8
9. Mitosis … continued
In mitosis, the exact copy of genetic
information, stored within the
chromosomes, must be passed from the
mother cell to the two daughter cells.
Herlihy 2011, p.41
9
Document Title (Editable via ‘Slide Master’) | Page 9
10. Meiosis
Meiosis occurs only in sex cells and is a special kind
of cell division
See:
http://highered.mcgrawhill.com/sites/0072495855/student_view0/chapter28/animation__how_meiosis_
works.html
10Document Title (Editable via ‘Slide Master’) | Page 10
11. Back to Mitosis and the Cell Cycle
The cell cycle is the sequence of events that the cell
goes through from one mitotic division to the next
biology.clc.uc.edu
11Document Title (Editable via ‘Slide Master’) | Page 11
12. The Cell Cycle
The Cell Cycle is divided into two (2) major
phases
1. Interphase
2. Mitosis
12Document Title (Editable via ‘Slide Master’) | Page 12
13. Interphase
During this time the cell carries on with its normal
functions and gets ready for mitosis through
growth and DNA replication
Interphase has three (3) parts to it
1. First gap phase (G1)
2. Phase S
3. Second gap phase (G2)
13Document Title (Editable via ‘Slide Master’) | Page 13
14. FIRST GAP PHASE (G1)
The cell carries on it normal activities and
begins to make DNA and other substances
necessary for cell division
apbio82007.blogspot.com
14Document Title (Editable via ‘Slide Master’) | Page 14
15. PHASE (S)
During Phase (S) the cell duplicates its
chromosomes and makes enough DNA for
two (2) identical cells
zebrafish.umdnj.edu
15Document Title (Editable via ‘Slide Master’) | Page 15
16. SECOND GAP PHASE (G2)
This phase is the final preparatory phase for
cell division (mitosis)
It includes the synthesis of enzymes and other
protein needed for mitosis
At the completion of G2 the cell enters into the
mitotic (M) phase
Herlihy 2011, p.41
16Document Title (Editable via ‘Slide Master’) | Page 16
17. MITOSIS
(M Phase)
During M Phase the cell divides into two (2) cells in
such a way that the nuclei of both cells contain
identical genetic information
Herlihy 2011, p.41
17Document Title (Editable via ‘Slide Master’) | Page 17
18. Mitosis has four (4) phases:
1.
2.
3.
4.
Prophase
Metaphase
Anaphase
Telophase
http://highered.mcgrawhill.com/sites/0072495855/student_view0/chapter2/animation__mitosis_and_cytokinesis.h
tml
18Document Title (Editable via ‘Slide Master’) | Page 18
19. What Next?
At the end of mitosis the daughter cells have a
choice of two pathways:
1. Enter G1 and repeat the cycle and divide again
2. Enter G-zero (G0) and ‘drop out’ of the
cell cycle and rest; they do not
undergo mitosis.
19Document Title (Editable via ‘Slide Master’) | Page 19
20. HOW LONG CAN CELLS ‘REST’ FOR?
Cells may re-enter the cell cycle after days, weeks or
even years
Cancer cells do not appear to be able to stop ‘cycling’
or enter the G0 phase
Cancer cells constantly divide and proliferate
Herlihy 2011, p.42
20Document Title (Editable via ‘Slide Master’) | Page 20
21. TREATING CANCER
Anti-cancer drugs work more successfully on cells
that are ‘cycling’ rather than ones that are ‘resting’
in the G0 phase
Tumours that contain many cycling cells respond
best to chemotherapy
21Document Title (Editable via ‘Slide Master’) | Page 21
22. ANTI CANCER DRUGS
Anticancer drugs are classified according to the cell
cycle phase they affect
Some anti-cancer drugs are called cell cycle-phase
specific
These drugs affect cells when they are in a
particular phase
Herlihy 2011, p.42
22Document Title (Editable via ‘Slide Master’) | Page 22
23. For Example
The anti-cancer drug methotrexate is cell cycle S phase
specific
Some drugs work in the M phase or in the G2 phase
Other anti-cancer drugs can work in any phase of the
cell cycle and are called cell cycle-phase non specific
http://www.oncolink.org/treatment/section.cfm?c=9&s=70
23Document Title (Editable via ‘Slide Master’) | Page 23
24. CELL DIFFERENTIATION
Mitosis ensures that when one cell divides it
produces two (2) identical cells
An embryo begins life as a single cell, the fertilised
ovum, and through mitosis the single cell divides
many more times into identical cells
Herlihy 2011, p.42
24Document Title (Editable via ‘Slide Master’) | Page 24
25. Sometime during their development the cells
begin to specialise, or differentiate
One cell may switch on enzymes that make red
blood cells while another cell may make bone
cells
We all begin life as one cell and end up as
billions of specialised cells
25Document Title (Editable via ‘Slide Master’) | Page 25
26. When differentiation goes wrong!
When a sample of tissue (a biopsy) is
surgically removed for examination it may
show many poorly differentiated cells
This means that the cells have failed to
differentiate or specialise.
26Document Title (Editable via ‘Slide Master’) | Page 26
27. For example un-differentiated cells found in a
liver tumour do not resemble normal liver cells
Failure to differentiate is characteristic of cancer
cells
Herlihy 2011, p.42
27Document Title (Editable via ‘Slide Master’) | Page 27
29. STEM CELLS
Stem cells are relatively un-differentiated or unspecialised cells and their job is to produce additional
un-specialised cells
Every time a stem cell divides one of the daughter cells
differentiates while the other daughter cell prepares for
further stem cell division
The rate of stem cell division varies with the tissue type
29Document Title (Editable via ‘Slide Master’) | Page 29
30. For Example
Stem cells in the bone marrow and skin are
capable of dividing more than once a day, but
adult cartilage stem cells may remain inactive for
years.
With ongoing ethical research there may be the
potential here to replace damaged body
components, like the spinal cord for example.
Herlihy 2011, p.43
30Document Title (Editable via ‘Slide Master’) | Page 30
31. ORDER & DISORDER
Most cell growth is orderly, but sometimes this
process becomes disorderly and un-controlled
When too many cells are produced a lump or a
tumour forms.
Tumours are either benign (not cancerous) or
malignant (cancerous).
Herlihy 2011, p.43
31Document Title (Editable via ‘Slide Master’) | Page 31
33. Benign Breast Tumour (mammogram)
33Document Title (Editable via ‘Slide Master’) | Page 33
34. PROGRAMMED CELL DEATH
This process is known as apoptosis and is
essentially cell suicide
Apoptosis helps ride the body of old, unnecessary and unhealthy cells.
The body produces a million cells per second
the elimination of some cells by apoptosis is
necessary
Herlihy 2011, p.43
34Document Title (Editable via ‘Slide Master’) | Page 34
35. Apoptosis can become uncontrolled and this
results in excessive cellular death and disease
apoptosis-networks.eu
35Document Title (Editable via ‘Slide Master’) | Page 35
36. When cancer cells spread they are said to
metastasise
Sometimes cells are so badly injured that they die
or necrose.
Herlihy 2011, p.44
36Document Title (Editable via ‘Slide Master’) | Page 36
37. REFERENCE
Herlihy, B. (2011) The Human Body in Health and Illness, 4th
Edition, Elsevier Saunders
37Document Title (Editable via ‘Slide Master’) | Page 37